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The Aire family expands
Adrian Liston and James Dooley
T cell tolerance depends upon Aire-expressing cells to purge the T cell repertoire of autoreactive clones. Once thought to be the exclusive
domain of thymic epithelial cells, a new study by Yamano et al. (https://doi.org/10.1084/jem.20181430) in this issue of JEM identiﬁes ILC3-like
cells in the lymph nodes with similar properties.
The transcription factor Aire is well char-
acterized as a key player in T cell tolerance
in the thymus. In the current issue of JEM,
Yamano et al. identify the long-elusive pe-
ripheral counterpart, as innate lymphocyte
cells (ILCs) join the Aire-expressing family.
Aire has a critical function in thymic T cell
tolerance as the driver of ectopic expression
of tissue-restricted antigens (TRAs) in the
thymic epithelium. This thymic expression
of TRAs allows differentiating T cells to be
exposed to the full range of peripheral an-
tigens, purging the T cell repertoire of au-
toreactive T cells before entering the
periphery (Anderson and Su, 2016). Muta-
tions in AIRE disrupt this process, leading to
autoimmune polyglandular syndrome type
1 (APS-1), a severe multi-organ autoimmune
syndrome.
The mechanism of action of Aire in the
thymic epithelium is now understood in
stunning detail, from the molecular inter-
actions occurring at TRA promoters through
to the cellular processes of negative selec-
tion and regulatory T cell induction. Despite
this wealth of knowledge, there have been
clues from the beginning that we were
missing part of the story. The known auto-
immune targets following Aire mutation are
mismatched from the set of Aire-dependent
TRAs expressed in the thymus, hinting at
mechanisms other than simple thymic ex-
pression. The key suspect has long been
peripheral expression of Aire. Early studies
identiﬁed Aire expression in peripheral
lymphoid tissues (Nagamine et al., 1997).
The generation of an Aire-reporter strain
provided conclusive evidence for an Aire-
expressing peripheral population (Gardner
et al., 2008), however the identity of this
population has proven elusive, being vari-
ously described as an atypical stromal cell
(Gardner et al., 2008) or a novel dendritic
cell–like population (Gardner et al., 2013).
The work by Yamano et al. (2019) ele-
gantly identiﬁes the true Aire-expressing
peripheral cell as an ILC3-like resident of
the lymph node. While diversity was ob-
served among cells expressing Aire at the
mRNA level, only ILC3-like cells expressed
Aire protein (Yamano et al., 2019). This
subset expressed Aire protein at a compa-
rable level to that of Aire-expressing epi-
thelial cells in the thymus. The other
putative Aire-expressing peripheral cells, by
contrast, demonstrated a clear discordance
between Aire mRNA and protein, suggest-
ing a biological basis for the long-simmering
controversy in previous attempts to deﬁne
peripheral Aire expression. The authors
deﬁned the Aire-expressing population as
ILC3-like based on lymphoid morphology
and phenotypic markers. Critically, the au-
thors formally demonstrated the hemato-
poietic, Rag-independent, Rorg-dependent
origin of these cells, placing them ﬁrmly
within the ILC3 family. As with Aire-
expressing thymic epithelial cells, Aire ex-
pression in ILC3-like cells is Rank dependent
(Rossi et al., 2007), although intriguingly (and
unlike the thymic counterpart), crosstalk
with T cells is not required for Aire-expressing
cells to emerge from the canonical ILC3
population.
The million-dollar question is whether
Aire-expressing ILC3-like cells have any
function. Do they express TRA, driving
tissue-speciﬁc tolerance like their thymic
counterpart? Or are they merely an epi-
phenomenon driven by a conserved Rank–
Aire pathway in irrelevant cells? The jury is
still out; however, this study provides two
intriguing data points. First, the transcrip-
tional impact of Aire on ILC3-like cells ap-
pears to be vastly different to that on thymic
epithelial cells. While Aire expression in
thymic epithelium drives TRA expression,
Aire expression in the periphery drives
largely nonoverlapping (or even opposing)
transcriptional effects, without a bias for
TRA (Yamano et al., 2019). In this respect,
Aire-expressing ILC3-like cells cannot be
seen to act as a peripheral safety net for
thymic tolerance. The second point, how-
ever, strongly argues in favor of a functional
role for Aire expression in ILC3-like cells.
Expression of a neo-self antigen by this
population resulted in efﬁcient in vivo de-
pletion of TCR-transgenic autoreactive T cells
(Yamano et al., 2019). The ILC3-like cells
are therefore not only effective antigen-
presenting cells, but appear to be endowed
with a strong tolerogenic function.
This study may close the book on the
identity of Aire-expressing cells in the pe-
riphery, but, if anything, it raises more
questions on the function of peripheral Aire
expression. Is this peripheral expression
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required to avert autoimmunity? Does Aire
expression impart the tolerogenic function
of ILC3-like cells, or merely provide a set of
antigens for these cells to present? Is the
population dynamically regulated with age
or during disease? Depending on the out-
come of these questions, Aire-expressing
ILC3-like cells may become a highly attrac-
tive target for therapeutic intervention. A
peripheral population with parallel tolero-
genic properties to thymic epithelial cells
would provide several key advantages over
the thymic counterpart, including accessi-
bility and the ability to shape the post-
thymic T cell repertoire. The identiﬁcation
of a suitable cellular host for tolerogenic
vaccines has the potential to reshape how
we treat autoimmune diseases.
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